Oki, Y., Fanale, M., Romaguera, J., Fayad, L., Fowler, N., Copeland, A., . . . Younes, A. (2015). Phase II study of an AKT inhibitor MK2206 in patients with relapsed or refractory lymphoma. Br J Haematol.
Citação norma ChicagoOki, Yasuhiro, et al. "Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma." Br J Haematol 2015.
Deismireacht MLAOki, Yasuhiro, et al. "Phase II Study of an AKT Inhibitor MK2206 in Patients With Relapsed or Refractory Lymphoma." Br J Haematol 2015.
Rabhadh: D'fhéadfadh nach mbeadh na deismireachtaí seo 100% cruinn i gcónaí.